InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: misiu143 post# 119175

Saturday, 09/26/2020 9:47:42 AM

Saturday, September 26, 2020 9:47:42 AM

Post# of 233140
Again like NASH, AD is long term trial and much higher rate of failure - lik 99%.

CCR5 and AD are remotely connected if at all. Just because Lero crosses BBB does not mean it will have impact on AD.
It is likely to have better results in glioblastoma as it is brain cancer.

In reality- CYDY has much more than they can even tough - so focus on
COVID
Cancer
HIV
GVHD

Show good progress in them and get one approval - that will allow them to be bought at good price. There is no need to target any long term indications
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News